Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO)
Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Rolf A. Stahel(International Breast Cancer Study Group), Paolo G. Casali(Fondazione IRCCS Istituto Nazionale dei Tumori), Alexander M.M. Eggermont(University Medical Center Utrecht), Alexandru Eniu(Institute of Oncology Prof. Dr. Ion Chiricuta), Solange Peters(University Hospital of Lausanne), Keith McGregor(Assistance Publique Hôpitaux de Marseille), Christoph Zielinski(Vienna General Hospital), Martine Piccart(Université Libre de Bruxelles), Răzvan Popescu(Hirslanden Klinik Aarau), Eric Van Cutsem(Universitair Ziekenhuis Leuven), Andrés Cervantes(INCLIVA Health Research Institute), J.-Y. Douillard(European Society for Medical Oncology), Dirk Arnold(Asklepios Klinik Altona)
Cited by 126
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k